Shenzhen Hepalink Pharmaceutical Group Overview

  • Founded
  • 1998
Founded
  • Status
  • Public
  • Employees
  • 2,162
Employees
  • Stock Symbol
  • 002399
Stock Symbol
  • Investments
  • 12
  • Share Price
  • $2.66
  • (As of Thursday Closing)

Shenzhen Hepalink Pharmaceutical Group General Information

Description

Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company engaged in the supply of heparin sodium drugs. The company distributes its products both in the domestic and overseas markets. Its projects portfolio includes National Bio-High Technology Industrialization Demonstration, the National Torch Program, and the National Key Technology Innovation Project.

Contact Information

Formerly Known As
Shenzhen Hepalink Pharmaceutical
Ownership Status
Publicly Held
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
SHE
Primary Office
  • Ke Xing Lu
  • Shenzhen Shi, Guangdong Sheng 518057
  • China
+86 0755 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Shenzhen Hepalink Pharmaceutical Group Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.66 $2.66 $2.50 - $4.41 $3.67B 1.47B 4.22M $0.12

Shenzhen Hepalink Pharmaceutical Group Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 5,361,529 4,148,737 4,592,670 3,002,097
Revenue 717,068 669,305 727,855 420,749
EBITDA 257,996 159,513 42,459
Net Income 156,398 153,316 89,408 29,101
Total Assets 2,711,893 2,178,454 1,977,356 2,146,619
Total Debt 826,231 899,918 714,630 779,419
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Shenzhen Hepalink Pharmaceutical Group Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Shenzhen Hepalink Pharmaceutical Group‘s full profile, request access.

Request a free trial

Shenzhen Hepalink Pharmaceutical Group Executive Team (4)

Name Title Board Seat Contact Info
Li Li Co-Founder, President & Chairman of Board
Zhang Bin Chief Financial Officer
Li Tan Co-Founder & Executive Director & Deputy General Manager
Bu Haihua Vice President, Board Member & Board Secretary
To view Shenzhen Hepalink Pharmaceutical Group’s complete executive team members history, request access »

Shenzhen Hepalink Pharmaceutical Group Board Members (5)

Name Representing Role Since
00 000000 Shenzhen Hepalink Pharmaceutical Group Vice President, Board Member & Board Secretary 000 0000
00 00 Shenzhen Hepalink Pharmaceutical Group Co-Founder, President & Chairman of Board 000 0000
00000 00000000 Shenzhen Hepalink Pharmaceutical Group Independent Director 000 0000
00000 00000 Shenzhen Hepalink Pharmaceutical Group Chairman of the Supervisory Board 000 0000
To view Shenzhen Hepalink Pharmaceutical Group’s complete board members history, request access »

Shenzhen Hepalink Pharmaceutical Group Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Shenzhen Hepalink Pharmaceutical Group Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Shenzhen Hepalink Pharmaceutical Group‘s full profile, request access.

Request a free trial

Shenzhen Hepalink Pharmaceutical Group Investments & Acquisitions (12)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 14-Aug-2020 0000 00.000 Biotechnology
00000000000 01-Apr-2019 0000 000.00 Biotechnology
00000000 000000 00 27-Feb-2018 00000 0000000 Other Healthcare Services 00 00
00000000000 04-Dec-2017 0000 0000 Biotechnology
Resverlogix 20-Jun-2017 Public Investment 2nd Offering 00.000 Biotechnology
You’re viewing 5 of 12 investments and acquisitions. Get the full list »

Shenzhen Hepalink Pharmaceutical Group Subsidiaries (1)

Company Name Industry Location Founded
00000000 000 Pharmaceuticals 0000
To view Shenzhen Hepalink Pharmaceutical Group’s complete subsidiaries history, request access »

Shenzhen Hepalink Pharmaceutical Group Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 00000000000 01-Aug-2015 00000 00000 00 00.000 Completed
  • 00000000 00000000
To view Shenzhen Hepalink Pharmaceutical Group’s complete exits history, request access »